HQHaider Saddam Qasim

Haider Saddam Qasim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Haider Saddam Qasim has a total of 3 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Classical Machine Learning Versus Deep Learning for Network Intrusion Detection: Comparative Performance, Computational Cost, and Evidence Validity

    by Haider Saddam Qasim, Yi Lu

    Comparisons of classical machine learning (CML) and deep learning (DL) for network intrusion detection often conflate predictive accuracy, experimental validity, and deployment efficiency. This critical evidence synthesis examines how comparison boundaries shape reported CML–DL differences. Eighteen bounded ranked searches yielded 180 hit occurrences; of 111 reports sought, 36 could not be retrieved, and 24 were mapped. Thirty-four selected contrasts from 16 reports were recalculated without pooling heterogeneous metrics or treating dependent comparisons as independent studies. At zero margin, report patterns were seven CML-favouring, five DL-favouring, four mixed, and eight unassessable. Fourteen contrasts differed by less than one percentage point; a one-point threshold changed the pattern to five CML-favouring, seven DL-favouring, and four within-margin reports. Excluding three reports with undocumented architecture depth did not produce a stable ranking. Fourteen reports contained inference-related numbers, but only one offered a platform/workload-compatible CML–DL inference comparison. Threat-dependent reversals, uncertain partition alignment, and inconsistent measurement boundaries preclude a universal family ranking. The contribution is a traceable comparison-boundary framework, a resource-evidence audit, and the COMPARE-NIDS reporting checklist, rather than a pooled superiority estimate.

  • Open Access

    Artificial Intelligence Tools in Pre-Travel Health Consultations: A Scoping Review of Clinical Evidence, Implementation Gaps, and Emerging Opportunities

    by Haider Saddam Qasim, Maree Donna Simpson

    Background: Pre-travel health consultations require individualised risk assessment across itinerary, destination, traveller characteristics, vaccine and medication history, comorbidities, pregnancy and immune status, activities, and access to care. Artificial intelligence (AI), particularly large language models (LLMs), may support pre-consultation education, structured history collection, guideline retrieval, multilingual communication and post-consultation reinforcement, but unsafe use may introduce hallucinated, outdated or insufficiently personalised recommendations. Objectives: This scoping review maps the current evidence on AI tools relevant to pre-travel health consultations, characterises implementation gaps, identifies patient-safety risks and proposes a supervised implementation model for travel medicine clinics. Original contribution: Unlike previous reviews of clinical AI, patient-education LLMs or chatbots in chronic illness, this is the first scoping review focused specifically on AI in pre-travel consultations. It uniquely combines a five-tier evidence hierarchy that separates direct travel-medicine AI evidence from indirect clinical-AI safety and equity evidence, and provides a travel-medicine-specific clinical safety risk taxonomy and a supervised implementation framework anchored to authoritative travel-medicine guidance and current AI regulatory regimes. Methods: A scoping review was conducted following PRISMA-ScR reporting, using a Population–Concept–Context eligibility framework and a targeted retrieval in May 2026 covering January 2017 to May 2026. Sources were screened and charted by a single reviewer using a structured eligibility checklist. Quality and applicability were appraised conceptually using MMAT, AMSTAR 2 and JBI text-and-opinion criteria, with GRADE-informed certainty. Results: Of 70 records identified, 11 were included: four direct pre-travel AI sources, one adjacent travel-related decision-support study, four guideline and context sources and two clinical LLM safety sources. The only patient-level implementation involved 26 travellers using a GPT-4 Travel Clinic Assistant in Singapore, where physicians and travellers reported acceptability and workflow benefit but objective effectiveness outcomes were not measured. Broader clinical LLM evidence indicates heterogeneous evaluation methods, vulnerability to hallucinated guidelines, and accuracy that varies widely across model versions and specialties. Conclusions: Current evidence supports supervised AI augmentation of pre-travel consultations but does not support autonomous AI-led vaccine selection, malaria prophylaxis, contraindication screening or individualised travel-risk clearance. Near-term deployment should be restricted to clinician-supervised education, structured intake, source-grounded guideline retrieval, after-visit reinforcement and escalation-triggered workflow support. Priority research includes travel-medicine-specific hallucination audits; equity testing in visiting-friends-and-relatives, migrant, older-adult, First Nations Australian, and Pacific Islander travellers; and prospective trials reported under CONSORT-AI, SPIRIT-AI and TRIPOD + AI.

  • Open Access

    Artificial Intelligence Tools in Pre-Travel Health Consultations: A Scoping Review of Clinical Evidence, Implementation Gaps, and Emerging Opportunities

    by Haider Saddam Qasim, Maree Donna Simpson

    Background Pre-travel health consultations require individualised risk assessment across itinerary, destination epidemiology, traveller characteristics, vaccine history, comorbidities, medication profile, pregnancy status, immune status, activities, timing, and access to care [8,10,11]. Artificial intelligence (AI), particularly large language models (LLMs), may support pre-consultation education, structured history collection, guideline retrieval, multilingual communication, and post-consultation reinforcement, but unsafe use may introduce hallucinated, outdated, or insufficiently personalised recommendations [5,6,14,15]. Objectives This scoping review maps the current evidence on AI tools relevant to pre-travel health consultations, characterises implementation gaps, identifies patient-safety risks, and proposes a supervised implementation model for travel medicine clinics [1,28-30]. Methods The review was conducted as a scoping review using the Arksey and O'Malley framework as advanced by Levac and colleagues and operationalised through the JBI scoping review guidance, with reporting aligned to the PRISMA Extension for Scoping Reviews (PRISMA-ScR) [1,28-30]. The review was not prospectively registered. Eligibility was defined by a Population–Concept–Context (PCC) framework. Targeted retrieval was conducted in May 2026 through PubMed/MEDLINE (one direct search string), academic and web-indexed search tools, citation chasing from Journal of Travel Medicine and Travel Medicine and Infectious Disease, and authoritative guideline and regulator websites. The search date range was January 2017 to May 2026. Sources were eligible if they addressed AI or digital decision support in pre-travel health, travel medicine, travel-related clinical decision support, clinical LLM safety, or guidance defining the standard pre-travel consultation. Screening and data charting were conducted by a single reviewer using a structured eligibility checklist (Supplement S2). Results Seventy records were identified, one duplicate was removed, 69 records were screened, 12 reports were sought for retrieval, one record could not be retrieved within the search window, and 11 reports were assessed in full text and included in the synthesis. Included sources comprised four direct pre-travel AI sources, one travel-related decision-support study, four guideline and context sources, and two clinical LLM safety sources. Direct evidence is thin: the only patient-level implementation report involved 26 travellers using a GPT-4 Travel Clinic Assistant in a Singapore tertiary travel clinic, where physicians and travellers reported acceptability and workflow benefit but objective effectiveness outcomes were not measured [3]. A ChatGPT pre-travel advice evaluation found generally readable and comprehensive answers to common questions, but responses lacked sufficient personalisation to itinerary, comorbidity, vaccine history, and cost considerations [2]. Broader clinical LLM evidence indicates that evaluation methods remain heterogeneous and that LLMs may repeat or elaborate false clinical details and hallucinate clinical guidelines in simulated decision-support tasks [13,14,16]. Conclusions Current evidence supports supervised AI augmentation of pre-travel consultations but does not support autonomous AI-led vaccine selection, malaria prophylaxis, contraindication screening, or individualised travel-risk clearance [2-6,14,15,48,50]. Near-term deployment should be restricted to clinician-supervised education, structured intake, source-grounded guideline retrieval, after-visit reinforcement, and escalation-triggered workflow support [4,5,34,49]. Travel medicine specialists, clinic leaders, regulators, and digital health developers should prioritise domain-specific hallucination audits, equity testing across visiting friends and relatives, migrant, older-adult, First Nations Australian, and Pacific Islander travellers, and prospective trials reported under CONSORT-AI, SPIRIT-AI, and TRIPOD+AI standards [31-33,37,38,41-44].

  • Open Access

    Systematic Evaluation Framework for ML and DL-Based Ransomware Detection

    by Haider Qasim, Yi Lu

    Cybercriminals have increasingly leveraged sophisticated techniques to bypass traditional signature-based detection systems through the use of Ransomware-as-a-Service (RaaS) platforms, double and triple extortion strategies, and advanced evasion mechanisms. As a result, ransomware attacks have reached unprecedented levels. Using this systematic evaluation framework, we examine the current state and effectiveness of machine learning (ML) and deep learning (DL) approaches for ransomware detection, addressing critical gaps in existing research methodologies while providing comprehensive recommendations for future research. The study analyses multiple AI paradigms including supervised learning algorithms such as Random Forests and Support Vector Machines, unsupervised techniques such as clustering and anomaly detection, and deep learning architectures such as Convolutional Neural Networks and Long Short-Term Memory networks. Hybrid approaches combining static and dynamic analysis consistently achieve superior performance, with accuracy rates exceeding 99% when properly implemented. As part of the framework, fundamental challenges are addressed such as dataset quality and diversity, feature extraction and selection methodologies, data preprocessing techniques, and performance evaluation metrics that have been tailored specifically for cybersecurity applications. Several findings indicate that ensemble learning methods outperform individual classifiers, with Random Forest algorithms being particularly effective at handling high-dimensional feature spaces while maintaining interpretability for security analysts. As a result of the study, significant limitations have been identified in current research, including an overreliance on static data sets that do not capture evolving threat landscapes, an inadequate representation of modern attack vectors, and a limited ability to generalize across different operational environments. Future directions of this research include explainable AI integration for transparent decision-making, adaptive real-time detection systems, and federated learning approaches for collaborative threat intelligence sharing while maintaining organizational privacy. It provides standardized methodologies for data curation, feature engineering, model development, and performance benchmarking, enabling fair comparisons between different AI approaches and facilitating reproducible research. This work contributes to essential guidance for cybersecurity practitioners, policymakers, and researchers in developing robust, adaptive, and interpretable ransomware detection systems capable of defending against increasingly sophisticated cyber threats while considering ethical concerns and regulatory compliance requirements in modern digital ecosystems.


  • Open Access

    A Comparative Evaluation of Machine Learning and Deep Learning Models for Healthcare Ransomware Prediction: Architecture Alignment, Feature Importance, and Deployment Strategy

    by Haider Saddam Qasim, Yi Lu

    In healthcare organizations, ransomware threats are on the rise, resulting in a greater disruption of critical patient care operations, yet current cybersecurity approaches are mostly reactive rather than proactive. As part of this study, a systematic comparative evaluation of traditional machine learning versus deep learning methodologies on small-scale tabular cybersecurity datasets characteristic of healthcare security operations is conducted to address the critical knowledge gap regarding optimal algorithmic approaches for healthcare ransomware threat prediction. In this study, the Healthcare Ransomware Dataset is used, which contains 5,000 simulated attack records with no missing values across 16 attributes capturing organizational attributes, attack characteristics, and outcome metrics. This study evaluated eight machine learning algorithms (Logistic Regression, Decision Tree, Random Forest, Gradient Boosting, Extra Trees, AdaBoost, Naive Bayes, K-Nearest Neighbors) and eight neural network architectures (Simple Deep Neural Network, Wide Deep Neural Network, Residual DNN, CNN_1D, LSTM, GRU, Ensemble DNN) across five performance dimensions: accuracy, precision, recall, F1-score, and ROC-AUC. According to the feature importance analysis, there is a strong correlation between organizational size (27.94%), recovery time (16.18%), and data restoration (12.06%) which account for 56% of the predictive power. A gradient boosting approach achieved 84.1% accuracy with 95.19% ROC-AUC and Simple DNN represented the best deep learning architecture with 85.2% accuracy and 95.44% ROC-AUC using only 12,355 parameters. As compared to machine learning (5.19%), deep learning demonstrated significantly lower performance variance (1.64% standard deviation). Across all sequence architectures (CNN_1D, LSTM, GRU), sequential architectures consistently underperformed by 2.6-4.5 percentage points, confirming the architectural mismatch for unordered tabular features. Based on the results of the analysis, Simple DNN provides the highest predictive accuracy (85.2%) for healthcare ransomware threat assessment. The complexity of an architecture beyond shallow dense networks yields diminishing returns without improving accuracy. In comparison to traditional machine learning ap-proaches, deep learning offers superior consistency across a variety of architectures. It is recommended that Simple DNN be de-ployed as the primary prediction model and Gradient Boosting be used as the fault-tolerant backup model. It is important to place a high priority on the eight top features that capture 90 percent of the predictive power of data. In the case of unordered tabular cybersecurity data, sequential architectures (CNNs, LSTMs, GRUs) should be avoided.

  • Open Access

    Clinical and Operational Applications of Artificial Intelligence and Machine Learning in Pharmacy: A Narrative Review of Real-World Applications

    by Maree Donna Simpson, Haider Saddam Qasim

    Over the past five years, the application of artificial intelligence (AI) including its significant subset, machine learning (ML), has significantly advanced pharmaceutical procedures in community pharmacies, hospital pharmacies, and pharmaceutical industry settings. Numerous notable healthcare institutions, such as Johns Hopkins University, Cleveland Clinic, and Mayo Clinic, have demonstrated measurable advancements in the use of artificial intelligence in healthcare delivery. Community pharmacies have seen a 40% increase in drug adherence and a 55% reduction in missed prescription refills since implementing artificial intelligence (AI) technologies. According to reports, hospital implementations have reduced prescription distribution errors by up to 75% and enhanced the detection of adverse medication reactions by up to 65%. Numerous businesses, such as Atomwise and Insilico Medicine, assert that they have made noteworthy progress in the creation of AI-based medical therapies. Emerging technologies like federated learning and quantum computing have the potential to boost the prediction of protein–drug interactions by up to 300%, despite challenges including high implementation costs and regulatory compliance. The significance of upholding patient-centred care while encouraging technology innovation is emphasised in this review.